CALCIUM GLUCEPTATE Drug Patent Profile
✉ Email this page to a colleague
When do Calcium Gluceptate patents expire, and what generic alternatives are available?
Calcium Gluceptate is a drug marketed by Abbott, Abraxis Pharm, and Lilly. and is included in four NDAs.
The generic ingredient in CALCIUM GLUCEPTATE is calcium gluceptate. There are two hundred and eighty-two drug master file entries for this compound. Additional details are available on the calcium gluceptate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CALCIUM GLUCEPTATE?
- What are the global sales for CALCIUM GLUCEPTATE?
- What is Average Wholesale Price for CALCIUM GLUCEPTATE?
Summary for CALCIUM GLUCEPTATE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 29 |
| Patent Applications: | 814 |
| DailyMed Link: | CALCIUM GLUCEPTATE at DailyMed |
US Patents and Regulatory Information for CALCIUM GLUCEPTATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | CALCIUM GLUCEPTATE | calcium gluceptate | INJECTABLE;INJECTION | 080001-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | CALCIUM GLUCEPTATE | calcium gluceptate | INJECTABLE;INJECTION | 006470-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbott | CALCIUM GLUCEPTATE | calcium gluceptate | INJECTABLE;INJECTION | 083159-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abraxis Pharm | CALCIUM GLUCEPTATE | calcium gluceptate | INJECTABLE;INJECTION | 089373-001 | Apr 30, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
